Muscular LMNA-Interacting Protein (MLIP) is a protein that plays a critical role in the structure and function of muscle cells. The LMNA gene encodes lamins, which are structural proteins that provide support to the cell's nucleus. MLIP interacts with lamin A/C, a type of nuclear lamina protein, and is primarily expressed in cardiac and skeletal muscle tissues.MLIP has been implicated in various cellular processes, including muscle development, maintenance, and function. It is involved in the regulation of muscle cell differentiation, growth, and response to mechanical stress, suggesting its importance in overall muscle health.
Research has shown that MLIP is linked to muscle cell signaling pathways and may play a role in mediating cellular responses to stress and mechanical strain. These findings indicate that MLIP is integral to the adaptive mechanisms that allow muscle cells to respond to physiological demands and environmental stimuli.Moreover, MLIP has garnered attention due to its potential involvement in cardiac and skeletal muscle disorders. Studies have suggested that alterations in MLIP expression or function may contribute to conditions such as cardiomyopathy, muscular dystrophy, and other muscle-related diseases. In particular, MLIP's interaction with lamin A/C underscores its relevance in maintaining nuclear structural integrity, which is crucial for proper muscle function and stability.The precise molecular mechanisms through which MLIP operates are still being elucidated. However, its association with nuclear lamins and its impact on muscle cell physiology point to its significance in regulating muscle structure, function, and adaptation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lonafarnib | 193275-84-2 | sc-482730 sc-482730A | 5 mg 10 mg | $173.00 $234.00 | ||
Another farnesyltransferase inhibitor, used to modulate LMNA processing and potentially its interactions. | ||||||
Pravastatin, Sodium Salt | 81131-70-6 | sc-203218 sc-203218A sc-203218B | 25 mg 100 mg 1 g | $68.00 $159.00 $772.00 | 2 | |
A statin that can inhibit farnesyltransferase indirectly, affecting LMNA processing and interactions. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Similar to Pravastatin, it can indirectly influence LMNA processing and interactions. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $90.00 $251.00 | 5 | |
A bisphosphonate that inhibits farnesyl pyrophosphate synthase, potentially impacting LMNA interactions. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Involved in gene expression regulation, could indirectly affect LMNA interactions. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
A sirtuin activator, potentially influencing LMNA function and its protein interactions. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Another histone deacetylase inhibitor, might influence LMNA function and its interacting proteins. | ||||||